However, it is important to note that our study was not intended to develop an immunoassay for diagnosis of anti-NMDAR1 encephalitis, but rather a prototype of a new immunoassay to quantify plasma anti-NMDAR1 autoantibodies across different species. The gene discussed is GRIN1; the disease is encephalitis.